Immune checkpoint inhibitors in cholangiocarcinoma
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 25, 2023 Category: Allergy & Immunology Authors: Nina Beri Source Type: research
Moving beyond single-agent checkpoint inhibition in biliary tract cancers: what is the next frontier?
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 25, 2023 Category: Allergy & Immunology Authors: Pedro Luiz Serrano Uson Junior Tanios Bekaii-Saab Source Type: research
Establishment of humanized mice and its application progress in cancer immunotherapy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 25, 2023 Category: Allergy & Immunology Authors: Tianlong Ding Yang Yu Xiaoyuan Pan Hao Chen Source Type: research
Cost –effectiveness of adjuvant atezolizumab for patients with stage II–IIIA PD-L1+ non-small-cell lung cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 6, 2023 Category: Allergy & Immunology Authors: Millie Das Sarika Ogale Nick Jovanoski Ann Johnson Caroline Nguyen Jan Bhagwakar Janet S Lee Source Type: research
The evolution of biliary tract cancer: introducing a special focus issue from Immunotherapy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 6, 2023 Category: Allergy & Immunology Authors: Lauren Coyle Alessandro Rizzo Dalia Ricci Source Type: research
Anlotinib succeeded in rescue therapy for hyperprogression induced by immune checkpoint inhibitors: a case report
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 6, 2023 Category: Allergy & Immunology Authors: Lu Chen Danna Liu Yujie Zhang Yuchang Jia Xiaoli Zhao Mengmeng Liu Tiandong Kong Source Type: research
Metastatic germ cell tumor showing a durable response to the anti-PD-1 antibody toripalimab
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 6, 2023 Category: Allergy & Immunology Authors: Ruiqi Wang Wanning Wang Wenlong Zhang Yuansong Bai Source Type: research
Ustekinumab in enteropathic arthritis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 6, 2023 Category: Allergy & Immunology Authors: Bahar Özdemir Ulusoy Abdulsamet Erden Serdar Can G üven Berkan Arma ğan Öykü Tayfur Yürekli Yasemin Özderin Özin Ahmet Omma Orhan K üçükşahin Source Type: research
Clinical efficacy and safety of efgartigimod for treatment of myasthenia gravis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 4, 2023 Category: Allergy & Immunology Authors: Ajith Sivadasan Vera Bril Source Type: research
Dendritic cell-based immunotherapy: a potential player in oral cancer therapeutics
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 4, 2023 Category: Allergy & Immunology Authors: Ruby Dwivedi Rahul Pandey Shaleen Chandra Divya Mehrotra Source Type: research
Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 4, 2023 Category: Allergy & Immunology Authors: Rebecca Jeun Priyanka C Iyer Conor Best Victor Lavis Jeena M Varghese Sireesha Yedururi Veronica Brady Isabella C Glitza Oliva Ramona Dadu Denai R Milton Kristy Brock Sonali Thosani Source Type: research
Targeting PD-1/PD-L1 in biliary tract cancer: role and available data
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 3, 2023 Category: Allergy & Immunology Authors: Reem D Mahmood Kathryn Graham Jack Gleeson Richard A Hubner Juan W Valle Mair éad G McNamara Source Type: research
Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy?
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 3, 2023 Category: Allergy & Immunology Authors: Sasha-Jane Abi-Aad Joseph Zouein Antoine Chartouni Nabih Naim Hampig Raphael Kourie Source Type: research
Tofacitinib experience in patients with enteropathic arthritis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - April 3, 2023 Category: Allergy & Immunology Authors: P ınar Akyüz Dağlı Abdulsamet Erden Serdar Can G üven Berkan Arma ğan Öykü Tayfur Yürekli Yasemin Özderin Özin Ahmet Omma Orhan K üçükşahin Source Type: research
Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 23, 2023 Category: Allergy & Immunology Authors: Yinghong Zhai Fangyuan Hu Borui Zhu Jinfang Xu Xiaojing Guo Wentao Shi Xiang Zhou Yi Zheng Xiao Xu Xiaofei Ye Jia He Feng Xu Source Type: research
